HS_COLGALT2_1480597 QuantiNova LNA PCR Assay

GeneGlobe ID: SBH0236805 | Cat. No.: Varies | QuantiNova LNA PCR Assays for Real-Time PCR

Product Specification

Best coverage assay for COLGALT2
Assay targets 4 transcripts
Assay spans exon
Pre-designed assay for dPCR and qPCR.

null
Assay name​
HS_COLGALT2_1480597 QuantiNova LNA PCR Assay
Wet-lab verified​
no
Assay specification​
Best coverage assay for COLGALT2
Assay targets 4 transcripts
Assay spans exon
Pre-designed assay for dPCR and qPCR.
Gene symbol​
COLGALT2
Gene aliases​
KIAA0584;C1orf17;GLT25D2
Species​
Homo sapiens
Main target​
ENST00000649786
Exons numbers​
9-10
Ensembl exons ids​
ENSE00000959465, ENSE00000959464
Amplicon start​
1625
Amplicon length​
114
Assay targets​
Transcript Ensembl Id
Bio Type
Ccds
Ref Seq
Chromosome Location
ENST00000361927
Protein coding
CCDS1360
NM_001303421;NM_015101
Chr.1: 183935834 - 184037728
ENST00000367520
Protein coding
Chr.1: 183937965 - 183964500
ENST00000367521
Protein coding
Chr.1: 183935837 - 183946618
ENST00000649786
Protein coding
NM_001303420
Chr.1: 183929854 - 184037729

Resources

User Manuals (1)
Safety Data Sheets (1)
Download Safety Data Sheets for QIAGEN product components.
Certificates of Analysis (1)
Introducing the HS_COLGALT2_1480597 QuantiNova LNA PCR Assay, a cutting-edge addition to our QuantiNova LNA PCR Assays for Real-Time PCR lineup, specifically designed for RNA expression applications. This premium product offers unparalleled performance for researchers working with Human models. Leveraging advanced technology, the HS_COLGALT2_1480597 QuantiNova LNA PCR Assay facilitates accurate and reliable results, making it an indispensable tool for your scientific investigations. Whether you're conducting RNA expression, or any other sophisticated analyses, this product from our QuantiNova LNA PCR Assays for Real-Time PCR collection ensures optimal efficiency and reproducibility for Human studies. Embrace the future of research with HS_COLGALT2_1480597 QuantiNova LNA PCR Assay and elevate your work to new heights.